Canine visceral leishmaniasis surveillance and monitoring application (PampaCare LVC) – a One Health approach in Uruguaiana (RS)
Vigil Sanit Debate, Rio de Janeiro, 2023, v.11: e02186 | Published on: 8/11/2023
DOI:
https://doi.org/10.22239/2317-269x.02186Keywords:
Leishmaniasis, One Health, Health Information SystemsAbstract
Introduction: Uruguaiana, a transmission area for Visceral Leishmaniasis (VL), is one of the five municipalities in Rio Grande do Sul with cases of Human Visceral Leishmaniasis (LVH). Objective: To introduce the development stages of PampaCare LVC as an application on the PampaCare platform, developed for monitoring and analyzing information on various diseases. Method: The application was designed to provide the migration process from a legacy system based on manual filling of forms to an automated tool. The development included the steps of gathering requirements, specifying use cases, defining the architecture, implementation, documentation and support. Flutter and Firebase technologies allowed for fast and efficient development while maintaining data quality and authentication security. 22 requirements were defined, translated into application functionalities. Results: The notification, geolocation of cases, data recording, report generation and epidemiological analysis stood out as functionalities. This information will help in the construction of alerts regarding the epidemiological situation of the neighborhoods, contributing to the environmental surveillance of territorial base in an assertive way. The Minimum Viable Product version was made available to the Environmental Health Surveillance Office in April 2023 and the final version will be released in August 2023. Conclusions: The application complied with 76% of the subcategories evaluated by the self-assessment technique, presenting satisfactory performance in terms of user experience and usability. After the updates, it is intended to reach 92% coverage of the subcategories that are part of the evaluation tool. Access to information from clinics and hospitals will enable greater robustness to the disease indicators, allowing the elaboration of public policies consistent with the reality in Uruguaiana.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Laura Ilarraz Massia, João Victor Charão Germain, Julia Birnie Farias, Fábio Paulo Basso, Débora da Cruz Payão Pellegrini (Autor)

This work is licensed under a Creative Commons Attribution 4.0 International License.
COPYRIGHT ALLOWANCE The author (s) hereinafter designated as the ASSIGNOR hereby assign and transfer, free of charge, the ownership of the copyrights related to this ARTICLE to the Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debate, represented by FUNDAÇÃO OSWALDO CRUZ, established at Av. Brasil, nº 4365, Manguinhos, Rio de Janeiro, RJ, Brazil, CEP 21045-900, under the conditions set out below: (a) The terms and conditions set forth in this Agreement shall apply to the following: 1. The ASSIGNOR declares that they s(he) is (are) the author (s) and owner (s) of the copyrighted property of the ARTICLE submitted. 2. The ASSIGNOR declares that the ARTICLE does not infringe the copyrights and / or other property rights of third parties, that the disclosure of images (if any) has been authorized and that they s(he) assume(s) full moral and / or property liability for its content, before third parties. 3. THE ASSIGNOR assigns and transfers all copyrights relating to the ARTICLE to the ASSIGNEE, especially the rights of editing, publication, translation into another language and reproduction by any process or technique. The ASSIGNEE becomes the exclusive owner of the rights related to the ARTICLE, and any reproduction, totally or partially, is prohibited in any other means of publicity, printed or electronic, without prior written authorization from the ASSIGNEE. 4. The assignment is free and, therefore, there will be no remuneration for the use of the ARTICLE by the ASSIGNEE.